Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 0.50 | 0.55 | 0.77 | 0.64 | 0.62 |
| Reported EPS($) | 0.52 | 0.60 | 0.83 | 0.65 | NA |
| GAAP($) | 0.30 | 0.33 | 0.51 | 0.39 | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 0.62 | 0.69 | 2.86 | 3.20 |
| Number of Analysts | 18 | 18 | 19 | 19 |
| Low Estimate ($) | 0.60 | 0.65 | 2.77 | 2.91 |
| High Estimate ($) | 0.67 | 0.72 | 2.91 | 3.52 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 0.62 | 0.69 | 2.86 | 3.20 |
| 30 Days Ago ($) | 0.63 | 0.69 | 2.87 | 3.20 |
| 90 Days Ago ($) | 0.64 | 0.65 | 2.79 | 3.02 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| MYL | 29.50% | 10.37% | 9.80% | 10.05 | 0.97 | |
